SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-046337
Filing Date
2024-05-23
Accepted
2024-05-23 17:20:48
Documents
14
Period of Report
2024-05-23
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0206820-8k_fresh2group.htm   iXBRL 8-K 38790
2 PRESS RELEASE DATED MAY 23, 2024 ea020682001ex99-1_fresh2.htm EX-99.1 6987
  Complete submission text file 0001213900-24-046337.txt   221522

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE fres-20240523.xsd EX-101.SCH 3006
4 XBRL LABEL FILE fres-20240523_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE fres-20240523_pre.xml EX-101.PRE 22353
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0206820-8k_fresh2group_htm.xml XML 3684
Mailing Address 650 FIFTH AVENUE SUITE 2416 NEW YORK NY 10019-6108
Business Address 650 FIFTH AVENUE SUITE 2416 NEW YORK NY 10019-6108 1 917-397-6890
Fresh2 Group Ltd (Filer) CIK: 0001786511 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8
Type: 8-K | Act: 34 | File No.: 001-39137 | Film No.: 24979711
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)